Tolododekin alfa Biosimilar – Research Grade from ProteoGenix; catalogue PX-TA2517; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Tolododekin alfa Biosimilar – Research Grade is a cutting-edge biotech product that offers a highly effective solution for a variety of therapeutic targets. This biosimilar is a biologically engineered version of Tolododekin alfa, a protein that plays a crucial role in the immune system.
One of the main applications of Tolododekin alfa Biosimilar – Research Grade is in the treatment of autoimmune diseases. This includes conditions such as rheumatoid arthritis, multiple sclerosis, and psoriasis. By targeting specific immune cells, Tolododekin alfa Biosimilar helps to regulate the immune response and reduce inflammation, providing relief for patients suffering from these debilitating diseases.
In addition to its use in autoimmune diseases, Tolododekin alfa Biosimilar – Research Grade also has potential in the field of cancer research. It has been shown to have anti-tumor effects by inhibiting the growth of certain cancer cells. This makes it a valuable tool for studying the mechanisms of cancer and developing new treatments.
The experimental use cases for Tolododekin alfa Biosimilar – Research Grade are vast and promising. Researchers are currently exploring its potential in the treatment of other inflammatory conditions, such as asthma and inflammatory bowel disease. It is also being studied for its ability to enhance the effectiveness of other cancer treatments, such as chemotherapy and radiation therapy.
Tolododekin alfa Biosimilar – Research Grade is a highly sought-after product in the biotech industry due to its unique biological function and wide range of applications. Its research grade status means it is of the highest quality and purity, making it an ideal choice for both academic and commercial research.
With its impressive therapeutic potential, Tolododekin alfa Biosimilar – Research Grade is a valuable addition to any laboratory or research facility. Its and concise product description make it a clear choice for those seeking a reliable and effective solution for their biotech needs. Don’t miss out on the opportunity to advance your research with Tolododekin alfa Biosimilar – Research Grade.
ProteoGenix catalogue number PX-TA2517. For research use only.
Target: Tolododekin alfa Biosimilar – Research Grade; Host: Mammalian cells; Clonality: Monoclonal antibody; Expression system: Mammalian; Purity: >95% as determined by SDS-PAGE; Buffer: 0.01 M PBS pH 7.4.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
